健脾消积口服液的研制

《健脾消积口服液的研制》由会员上传分享，免费在线阅读，更多相关内容在行业资料-天天文库。

1、目录摘要................................................................1英文搞要............................................................21.前言.............................................................32.材料与仪器........................................................42.1药材.......................

2、...................................42.2仪器..........................................................43.健脾消积口服液研究方法设计.......................................53.1药材制备及设定评价标准..........................................53.2对健脾消积口服液有影响的各单因素考察..............................63.3正交设计研究健脾消积口服液的工艺.........

3、.......................104.健脾消积口服液质量标准初步研究.................................135.讨论............................................................16结论...............................................................19参考文献...........................................................20致谢...............

4、................................................22-22-健脾消积口服液的研制摘要：目的分析处方的的合理性与观察理气健脾汤临床治疗功能性消化不良患者疗效和安全性方法：利用百度查找处方的作用，再取体质量适合的一定数量的小白鼠随机分分组。结果：健脾消积口服液对利血平所致的“脾虚”症状有明显的改善作用。结论：健脾消积口服液(1ml含生药量1g)具有健脾助运、消食化积之功效,关键词：消化不良；中医药疗法；理气健脾汤doi：10．3969／j．issn．1003—8914．2010．09．074文章编号：1003—8914(2010)一0

5、9．1445—02-22-Clinical~rvationonEfectofJianpiXiaojiOralLiquidin~eating40Patients、vitlIHepatocarcinomaStageⅡ、llIforSupplementaryII'ealmentHUANGZhi—fen，LIHan-zhong，SHIZhi—yan，etalDepartmentofTraditionalChineseandWesternMedicine，TumorHospital，GuangxiMedicalUniversity，Nanning(580021)objective~Tos

6、tudytheclinicaleffectofJianpiXiaojiOralLiquid(JXOL)intreatingpatientswithlatestagehepatocarcinomaforsupplementarytreatment．Methods：Seventy—fivepatientswererandomlydividedintothetreatedgroup(40patients)andthecontrolgroup(35patients)．Bothgroupsreceivedthesamewesternmedicaltreatment，includingth

7、esupportingtherapyandanalgesia，tothetreatedgroupJXOLwasadded．Theshort—termeffect，qualityoflife，changesofTCMSyndromeandimmunologiccriteriawereobserved．Results：Thecompleteremission(CR)rateinthetreatedgroupandthecontrolgroupwas5％and0respectively．stabl